NL-OMON33218Not yet recruitingNot Applicable
INTRAOPERATIVE REAL TIME IMAGING WITH A DUAL RADIOACTIVE/FLUORESCENCE MODALITY FOR SENTINEL NODE LOCALIZATION. A FEASIBILITY STUDY INCLUDING REPRODUCIBILITY OF MULTIMODALITY LYMPHATIC MAPPING WITH A COCKTAIL TRACER CONTAINING 99mTc NANOCOLLOID /ICG - RADIOACTIVE/FLUORESCENCE MODALITY FOR SENTINEL NODE LOCALIZATION.
Antoni van Leeuwenhoek Ziekenhuis0 sites40 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Patients presenting cutaneous melanoma of head/neck and upper part of the trunk
- •Patients presenting oral cavity malignances T1-2N0
- •Breast cancer patients with a medially located tumor (palpable tumors and non-palpable tumors detectable by ultrasound) with demonstrated drainage outside the axilla
- •Patients with clinical N0 stage
Exclusion Criteria
- •Evidence of regional or distant metastases
- •Non-palpable breast tumors requiring stereotaxis for tracer administration
- •Incapacity or unwillingness of participant to give written informed consent
- •Allergy to iodides
Investigators
Similar Trials
Recruiting
Not Applicable
iquid biopsy for early detection of cancerCTRI/2019/01/017219Datar Cancer Genetics Limited
Completed
Not Applicable
Phase I Hybrid study: combined stereotactic radiotherapy and conventional fractionation in stage II and III non small cell lung cancer with peripheral tumors smaller than 5 cmNon small cell lung cancer10038666Lung cancerNL-OMON39053ederlands Kanker Instituut15
Active, not recruiting
Not Applicable
Combined stereotactic radiotherapy and conventional fractionation in stage II and II lungcancer.SCLC stage III or inoperable stage IIMedDRA version: 14.1Level: PTClassification code 10062041Term: Lung infiltration malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10023779Term: Large cell lung cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10025036Term: Lung adenocarcinoma stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10062042Term: Lung neoplasmSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10029520Term: Non-small cell lung cancer stage IIIASystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10025082Term: Lung disorderSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: PTClassification code 10025031Term: Lung adenocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10029521Term: Non-small cell lung cancer stage IIIBSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10025069Term: Lung carcinoma cell type unspecified stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10001250Term: Adenosquamous cell lung cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (inclEUCTR2012-002392-33-NLKI-AV
Active, not recruiting
Phase 1
Combined hypofractionated stereotactic body radiotherapy with immunomodulating systemic therapy for inoperable recurrent head and neck cancer.local, regional or combined locoregional recurrence of squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx in previously irradiated tissue, with former irradiation with curative intent.EUCTR2017-000133-31-BEZ Gent30
Completed
Not Applicable
High frequency and dynamic contrast-enhanced ultrasound for treatment follow up of patients with Crohn*s disease.chronic intestinal inflammation10017969Crohn's diseaseNL-OMON50449Academisch Medisch Centrum40